Physician profile
Andrew Charles Picel
NPI 1003012444
$5,030.62
in general payments reported to CMS, 2019-2025
20 companies · $708 in 2025
The $708 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $160 · 2021: $434 · 2022: $1,478 · 2023: $1,213 · 2024: $732 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570 · Travel and Lodging: $83.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,569.52 |
| Travel and Lodging | $83.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,421.30 | 2021-2024 | Jeti All In One Non-Sterile Kit, Perclose Prostyle |
| Boston Scientific Corporation | $858.74 | 2019-2025 | Embold Fibered, Obsidio, Therasphere Y90 Glass Microspheres 10 Gbq |
| Penumbra, INC. | $608.22 | 2019-2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $426.66 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Okami Medical, INC. | $314.85 | 2024-2025 | Lobo |
| Ethicon US, LLC | $241.21 | 2023-2024 | Neuwave |
| Viz.Ai, INC. | $183.04 | 2021 | |
| W. L. Gore & Associates, INC. | $179.62 | 2025 | Gore Viatorr Tips Endoprosthesis |
| Sirtex Medical INC | $160.44 | 2020 | |
| Trisalus Life Sciences, INC. | $148.59 | 2023-2024 | Trinav Infusion System |
| Galvanize Therapeutics, INC | $130.42 | 2023 | Aliya System |
| Cordis US Corp. | $126.45 | 2023 | Mynx Control |
| Angiodynamics, INC. | $94.99 | 2023 | Alphavac |
| Terumo Medical Corporation | $72.66 | 2022 | |
| Medtronic, INC. | $24.75 | 2025 | Onyx 18 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $20.39 | 2019 | |
| Covidien LP | $18.29 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Picel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.